Identification of differentially expressed genes in breast tumors from African American compared with Caucasian women

Cancer

Volumn 118, Issue 5, 2012, Pages 1334-1344

  Field, Lori A ^a   Love, Brad ^b   Deyarmin, Brenda ^a   Hooke, Jeffrey A ^c   Shriver, Craig D ^c   Ellsworth, Rachel E ^d  

^a WINDBER RESEARCH INSTITUTE   (United States)

^b BioReka   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d Henry M Jackson Foundation for the Advancement of Military Medicine   (United States)

Author keywords

African American; breast cancer; disparities; gene expression; microarray

Indexed keywords

CRYBB2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROTEIN; PSPHL PROTEIN; SOS PROTEIN; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CAUCASIAN; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; CRYBB2 GENE; FEMALE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSPHL GENE; REAL TIME POLYMERASE CHAIN REACTION; SOCIAL STATUS; SOS1 GENE; TISSUE MICROARRAY; TUMOR VOLUME;

ADULT; AFRICAN AMERICANS; AGED; BREAST NEOPLASMS; CARCINOMA; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MICROARRAY ANALYSIS; MIDDLE AGED; POLYMERASE CHAIN REACTION; VALIDATION STUDIES AS TOPIC;

EID: 84857373457     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26405     Document Type: Article

References (42)

1. American Cancer Society. Breast Cancer Facts and Figures: 2009-2010. Atlanta, GA, American Cancer Society; 2009.
2. US Census Bureau. The American Community-Blacks: 2004. Washington, DC: US Department of Commerce, Economics and Statistics Administration; 2007.
3. Centers for Disease Control and Prevention. Racial and ethnic differences in breastfeeding initiation and duration, by state. National Immunization Survey, United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2010; 59: 327-334.
4. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM,. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295: 1549-1555.
5. Rose DP, Haffner SM, Baillargeon J,. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev. 2007; 28: 763-777. (Pubitemid 350294295)
6. Elledge RM, Clark GM, Chamness GC, Osborne CK,. Tumor biologic factors and breast cancer prognosis among white, Hispanic and black women in the United States. J Natl Cancer Inst. 1994; 86: 705-712. (Pubitemid 24138977)
7. Amend K, Hicks D, Ambrosone CB,. Breast cancer in African-American women: differences in tumor biology from European-American women. Cancer Res. 2006; 66: 8327-8330. (Pubitemid 44449138)
8. Stead LA, Lash TL, Sobieraj JE, et al. Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res. 2009; 11: R18.
9. Lund MJ, Butler EN, Bumpers HL, et al. High prevalence of triple-negative tumors in an urban cancer center. Cancer. 2008; 113: 608-615.
10. Morris GJ, Naidu S, Topham AK, et al. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database. Cancer. 2007; 110: 876-884. (Pubitemid 47257667)
11. Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295: 2492-2502. (Pubitemid 43854964)
12. Smid M, Wang Y, Zhang Y, et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 2008; 68: 3108-3114.
13. Sorlie T, Perou CM, Tibshirania R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98: 10869-10874. (Pubitemid 32878711)
14. Ellsworth RE, Zhu K, Bronfman L, Gutchell V, Hooke JA, Shriver CD,. The Clinical Breast Care Project: an important resource in investigating environmental and genetic contributions to breast cancer in African American women. Cell Tissue Bank. 2008; 9: 109-120. (Pubitemid 351663426)
15. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
16. Bloom HJ, Richardson WW,. Histological grading and prognosis in breast cancer. Br J Cancer. 1957; 11: 359-377.
17. Elston CW, Ellis IO,. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology. 1991; 19: 403-410.
18. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-408. (Pubitemid 34164012)
19. Martin DN, Boersma BJ, Yi M, et al. Differences in the tumor microenvironment between African-American and European-American breast cancer patients. PLoS One. 2009; 4: e4531.
20. Allinen M, Beroukhim R, Cai L, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004; 6: 17-32. (Pubitemid 38903159)
21. Albain KS, Unger JM, Crowley JJ, Coltman CA, Hershman DL,. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009; 101: 984-992.
22. Wallace TA, Prueitt RL, Yi M, et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 2008; 68: 927-936. (Pubitemid 351206772)
23. Ferguson SE, Olshen AB, Levine DA, Viale A, Barakat RR, Boyd J,. Molecular profiling of endometrial cancers from African-American and Caucasian women. Gynecol Oncol. 2006; 101: 209-213.
24. Maxwell GL,. Gynecologic Cancer Center for Racial Disparities. Annual Addendum, 2008. Available at:.
25. Planitzer SA, Wachl AW, Rueckels M, Kubbies M,. Identification of a novel c-DNA overexpressed in Fanconi's anemia fibroblasts partially homologous to a putative L-3-phosphoserine-phosphatase. Gene. 1998; 210: 297-306. (Pubitemid 28171452)
26. Kuo C-H, Miyazaki D, Nawata N, et al. Prognosis-determinant candidate genes identified by whole genome scanning in eyes with pterygia. Invest Ophthalmol Vis Sci. 2007; 48: 3566-3575. (Pubitemid 351261091)
27. Morley M, Molony CM, Weber TM, et al. Genetic variation of genome-wide variation in human gene expression. Nature. 2004; 430: 743-747. (Pubitemid 39071339)
28. Graw J,. Genetics of crystallins: cataract and beyond. Exp Eye Res. 2009; 88: 173-189.
29. Liedtke T, Schwamborn JC, Schroer U, Thanos S,. Elongation of axons during regeneration involves retinal crystallin beta b2 (crybb2). Mol Cell Proteomics. 2007; 6: 895-907. (Pubitemid 46831939)
30. Porfiri E, McCormick F,. Regulation of epidermal growth factor receptor signaling by phosphorylation of the ras exchange factor hSOS1. J Biol Chem. 1996; 271: 5871-5877. (Pubitemid 26083929)
31. Timofeeva OA, Zhang X, Ressom HW, et al. Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men. Int J Oncol. 2009; 35: 751-760.
32. Cohn MA, Kee Y, Haas W, Gygi SP, D'Andrea AD,. UAF1 is a subunit of multiple deubiquitinating enzyme complexes. J Biol Chem. 2009; 284: 5343-5351.
33. Baker EN,. Lactoferrin: a multi-tasking protein par excellence. Cell Mol Life Sci. 2005; 62: 2529-2530. (Pubitemid 41721227)
34. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y,. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. J Cell Biochem. 1999; 74: 486-498. (Pubitemid 29344898)
35. Ward PP, Paz E, Conneely OM,. Multifuctional roles of lactoferrin: a critical overview. Cell Mol Life Sci. 2005; 62: 2540-2548. (Pubitemid 41721229)
36. Jordan WJ, Eskdale J, Lennon GP, et al. A nonconservative, coding single-nucleotide polymorphism in the N-terminal region of lactoferrin is associated with aggressive periodontitis in an African-American, but not a Caucasian population. Genes Immun. 2005; 6: 632-635. (Pubitemid 41637671)
37. van den Boom J, Wolter M, Blaschke B, Knobbe CB, Reifenberger G,. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription- polymerase chain reaction. Int J Cancer. 2006; 119: 2330-2338. (Pubitemid 44546952)
38. Pils D, Horak P, Gleiss A, et al. Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival. Cancer. 2005; 104: 2417-2429. (Pubitemid 41691563)
39. Thomassen M, Tan Q, Kruse TA,. Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis. Breast Cancer Res Treat. 2009; 113: 239-249.
40. Xu J, Zheng SL, Isaacs SD, et al. Inherited genetic variant predisposes to aggressive but not indolent prostate cancer. Proc Natl Acad Sci U S A. 2010; 107: 2136-2140.
41. Walport MJ,. Complement. First of 2 parts. N Engl J Med. 2001; 344: 1058-1066.
42. Parker JS,., Mullins M, Cheang MCU, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009; 27: 1160-1167.